BIOE — Bio Essence Balance Sheet
0.000.00%
- $1.98m
- $2.89m
- $0.32m
Annual balance sheet for Bio Essence, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-Q | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.005 | 0 | 0.006 | 0 | 0.003 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.05 | 0.017 | 0.008 | 0.3 | 0.005 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.33 | 0.262 | 0.204 | 0.3 | 0.281 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.092 | 1.39 | 1.3 | 1.43 | — |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 1.85 | 1.7 | 1.55 | 2.76 | 0.281 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.89 | 2.76 | 3.56 | 2.45 | 2.8 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 3.63 | 4.13 | 4.79 | 4.42 | 3.25 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -1.78 | -2.43 | -3.24 | -1.66 | -2.97 |
| Total Liabilities & Shareholders' Equity | 1.85 | 1.7 | 1.55 | 2.76 | 0.281 |
| Total Common Shares Outstanding |